コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 f frataxin, the protein which is depleted in Friedreich ataxia.
2 ression and treatment effects in people with Friedreich ataxia.
3 l deficit and frataxin levels in people with Friedreich ataxia.
4 cluster biogenesis in mitochondria, such as Friedreich ataxia.
5 in healthy volunteers and participants with Friedreich ataxia.
6 th rapid development in controls, but not in Friedreich ataxia.
7 pastic paraplegia type 7 and very late-onset Friedreich ataxia.
8 tically contribute to the pathophysiology of Friedreich ataxia.
9 unclear where and how, and deficiency causes Friedreich ataxia.
10 tutes a new and useful model system to study Friedreich ataxia.
11 m underlying reduced frataxin mRNA levels in Friedreich Ataxia.
12 inant cause of transcriptional deficiency in Friedreich ataxia.
13 genesis of the most common recessive ataxia, Friedreich ataxia.
14 1 (SCA1), Machado-Joseph disease (MJD), and Friedreich ataxia.
15 ension (-14+/-6%), Fabry disease (-12+/-5%), Friedreich ataxia (-16+/-2%), or control subjects (-17+/
21 scuss the typical and atypical phenotypes of Friedreich ataxia and CANVAS, along with the features of
23 erences in the brain and spinal cord between Friedreich ataxia and controls, stratified by age and di
24 l sclerosis, nucleotide expansion disorders (Friedreich ataxia and fragile X syndrome), and cancer.
27 ac and brain MC1 density in a mouse model of Friedreich ataxia and in healthy volunteers and particip
28 s thought to underlie the pathophysiology of Friedreich ataxia and may occur at the expense of cytoso
29 ior cerebellar peduncles during childhood in Friedreich ataxia and open the way for the use of neuroi
30 h conditions that are recessively inherited, Friedreich ataxia and RFC1-associated cerebellar ataxia,
31 The effects were most pronounced for the Friedreich ataxia and the fragile X triplet repeat seque
32 tures reminiscent of mitochondrial myopathy, Friedreich ataxia, and 3-hydroxy-3-methylglutaryl-CoA ly
33 define the spectrum of pathogenic alleles in Friedreich ataxia, and demonstrate that expanded alleles
34 data on cystic fibrosis, Huntington disease, Friedreich ataxia, and progressive myoclonus epilepsy.
35 ity of borderline alleles confers a risk for Friedreich ataxia, and the range of pathogenic alleles i
36 ata indicate that expanded GAA-TR alleles in Friedreich ataxia are highly mutable and have a natural
37 ch corresponds to the expanded GAA repeat in Friedreich ataxia, as well as for ATT, CCT and GTT repea
38 the formation of non-B-DNA structures in the Friedreich ataxia-associated (GAA)n*(TTC)n repeats from
51 eat tracts are involved in the etiologies of Friedreich ataxia, fragile X syndrome, and myotonic dyst
53 e but not all patients with the rare disease Friedreich ataxia (FRDA) are at increased risk of poor c
55 incomplete shift of IRP1 to its ISC form in Friedreich ataxia (FRDA) fibroblasts, associated with de
78 Human frataxin (fxn) is severely reduced in Friedreich ataxia (FRDA), a frequent autosomal recessive
79 Frataxin deficiency is the primary cause of Friedreich ataxia (FRDA), an autosomal recessive cardiod
89 tein linked to the neurodegenerative disease Friedreich ataxia, has recently been proposed as an iron
90 found that approximately 20% of people with Friedreich ataxia have at least one such expanded compos
91 ss disease-modifying therapeutic advances in Friedreich ataxia, highlighting the most promising candi
92 ses including amyotrophic lateral sclerosis, Friedreich ataxia, Huntington disease, and fragile X syn
95 , analogous to disease-causing expansions in Friedreich ataxia, including two that are in introns of
109 rate that the GAA triplet repeat mutation in Friedreich ataxia is destabilized, frequently undergoing
111 e homolog of the human protein implicated in Friedreich ataxia, is involved in iron homeostasis.
115 ed arterial hypertension, Fabry disease, and Friedreich ataxia (n=25 per group) were investigated; 25
120 3) (prevalence, 3.1 per 100,000 population), Friedreich ataxia (prevalence, 1.0 per 100,000 populatio
121 luded standardized neurological assessments (Friedreich Ataxia Rating Scale [FARS], International Coo
122 xpression also inversely correlated with the Friedreich Ataxia Rating Scale score, an indicator of di
124 tive disorders such as mitochondrial ataxia, Friedreich ataxia, spinocerebellar ataxia type 2, ataxia
125 ses associated with oxidative stress such as Friedreich ataxia, spongiform encephalopathies, and Alzh
129 Fe-S cluster biogenesis has extended beyond Friedreich ataxia to include a sideroblastic anemia with
130 n healthy volunteers and in a mouse model of Friedreich ataxia versus wild-type mice (~50% reduction
131 [(18)F]BCPP-EF binding in participants with Friedreich ataxia was lower than that in healthy volunte
132 oncentrations are increased in patients with Friedreich ataxia, which supports the hypothesis that it